Supplementary File 2 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer

Supplementary File 2 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer

<p>Supplementary File 2: Excel file with CommunityAMARETTO Enrichment results</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Charles Blatti (15292859) (author)
Diğer Yazarlar:	Jesús de la Fuente (15292862) (author), Huanyao Gao (14962434) (author), Irene Marín-Goñi (15292865) (author), Zikun Chen (15292868) (author), Sihai D. Zhao (15292871) (author), Winston Tan (15035292) (author), Richard Weinshilboum (15292874) (author), Krishna R. Kalari (15099627) (author), Liewei Wang (14962464) (author), Mikel Hernaez (15292877) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Computational Methods Artificial intelligence & machine learning Drug Resistance Novel mechanisms Regulation of gene expression in drug resistance Gene Regulation Genitourinary Cancers Prostate cancer Systems Biology
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Supplementary File 3 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer
Yazar:: Charles Blatti (15292859)
Baskı/Yayın Bilgisi: (2025)

Supplementary File 4 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer
Yazar:: Charles Blatti (15292859)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Yazar:: Yufang Bao (15386826)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Yazar:: Yufang Bao (15386826)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S3 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Yazar:: Yufang Bao (15386826)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S4 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Yazar:: Yufang Bao (15386826)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S5 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Yazar:: Yufang Bao (15386826)
Baskı/Yayın Bilgisi: (2025)

Data file S1 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
Yazar:: Alex C.H. Liu (14961921)
Baskı/Yayın Bilgisi: (2025)

Data file S2 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
Yazar:: Alex C.H. Liu (14961921)
Baskı/Yayın Bilgisi: (2025)

Data file S3 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
Yazar:: Alex C.H. Liu (14961921)
Baskı/Yayın Bilgisi: (2025)

Data file S4 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
Yazar:: Alex C.H. Liu (14961921)
Baskı/Yayın Bilgisi: (2025)

Data file S5 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
Yazar:: Alex C.H. Liu (14961921)
Baskı/Yayın Bilgisi: (2025)

Table S1 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
Yazar:: Alex C.H. Liu (14961921)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data from <i>N</i><sup>6</sup>-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer
Yazar:: Jiachun Su (16990970)
Baskı/Yayın Bilgisi: (2025)

Figure S1 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Yazar:: Shiyi Yu (17079079)
Baskı/Yayın Bilgisi: (2025)

Figure S2 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Yazar:: Shiyi Yu (17079079)
Baskı/Yayın Bilgisi: (2025)

Figure S3 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Yazar:: Shiyi Yu (17079079)
Baskı/Yayın Bilgisi: (2025)

Figure S4 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Yazar:: Shiyi Yu (17079079)
Baskı/Yayın Bilgisi: (2025)

Figure S5 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Yazar:: Shiyi Yu (17079079)
Baskı/Yayın Bilgisi: (2025)

Figure S6 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Yazar:: Shiyi Yu (17079079)
Baskı/Yayın Bilgisi: (2025)

Figure S7 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Yazar:: Shiyi Yu (17079079)
Baskı/Yayın Bilgisi: (2025)

Figure S8 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Yazar:: Shiyi Yu (17079079)
Baskı/Yayın Bilgisi: (2025)

Supplementary Appendix S1 from DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
Yazar:: Bouchra Tawk (15389486)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table from CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization
Yazar:: Xiaohong Hong (22681698)
Baskı/Yayın Bilgisi: (2025)

Figure 1 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Figure 2 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Figure 3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Figure 4 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Figure 5 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Figure 6 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1-S3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
Yazar:: David Milewski (15050643)
Baskı/Yayın Bilgisi: (2025)

الذكاء الاصطناعي في المصارف الإسلامية: الضوابط والمعايير الشرعية
Yazar:: Al-amrkani, Wijdan Jubran Yousef
Baskı/Yayın Bilgisi: (2023)

Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer
Yazar:: Min Wei (16918572)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer
Yazar:: Min Wei (16918572)
Baskı/Yayın Bilgisi: (2025)

Supplemental Figure S1 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Yazar:: Jennifer L. Cotton (17315204)
Baskı/Yayın Bilgisi: (2025)

Supplemental Figure S2 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Yazar:: Jennifer L. Cotton (17315204)
Baskı/Yayın Bilgisi: (2025)

Supplemental Figure S3 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Yazar:: Jennifer L. Cotton (17315204)
Baskı/Yayın Bilgisi: (2025)

Supplemental Figure S4 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Yazar:: Jennifer L. Cotton (17315204)
Baskı/Yayın Bilgisi: (2025)

Supplemental Figure S5 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Yazar:: Jennifer L. Cotton (17315204)
Baskı/Yayın Bilgisi: (2025)

Supplemental Figure S6 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
Yazar:: Jennifer L. Cotton (17315204)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_ocqn9h64jnga5fc993fk1eivgd